eLetters

35 e-Letters

published between 2013 and 2016

  • Comment on 'Impact of UK Medical Eligibility Criteria implementation on prescribing of combined hormonal contraceptives'
    Sarah E Holden

    I read the article by Briggs and colleagues[1] with interest as it is, to my knowledge, the only study to assess the impact of the implementation of the UK Medical Eligibility Criteria on general practice prescribing of combined hormonal contraceptives (CHCs) in the UK. However, I have a study limitation.

    As the authors have stated, oral contraception can be accessed on prescription from a general practitioner (...

    Show More
  • Response to an unusual shaped IUS
    Adam Forrest

    I read with interest Dr MacGregor's letter[1] regarding the unusual shape of a Mirena intrauterine system (IUS) following removal. From the photograph it would appear that the capsule has become displaced and the arms of the device enclosed within it.

    We have seen a case of complete detachment of the capsule from the frame, with unrecognised retention of the capsule within the uterine cavity. This was only reco...

    Show More
  • Learning from Romanian women's struggle to manage their fertility
    Ann Furedi

    The commentary by Horga et al.[1] on the consequences of Ceausescu's attempt to ban abortion in Romania is a stark reminder of what happens when women are prevented from accessing safe and legal means to end problem pregnancies. In short, they end their pregnancies using means that are unlawful and/or unsafe, sometimes with tragic consequences.

    Although it is difficult to compare any country today with the repre...

    Show More
  • Contraceptive options for women with SLE: response to Mansour letter
    Kelly R Culwell

    We thank Dr Mansour for her interest in our article[1] and for her provocative questioning of the recommendations for use of progestogen-only contraceptives by women with systemic lupus erythematosus (SLE) who test positive for anti-phospholipid antibodies.[2] We are sensitive to any reductions in choice of contraceptive methods, particularly for women in whom pregnancy has significant health consequences, such as women w...

    Show More
  • Contraceptive options for women with SLE
    Diana Mansour

    May I congratulate the authors of the commentary describing contraceptive options for women with systemic lupus erythematosis (SLE).[1] This was a comprehensive summary and I was interested in their views regarding the suitability of progestogen-only methods in women with antiphospholipid antibodies. The authors felt these methods were unsafe in such women (World Health Organization Medical Eligibility Criteria for Contr...

    Show More

Pages